Colomycin (Forest Laboratories, UK) - one of the most “niche”, specialized products from Delta Medical portfolio, has an interesting promotion history that can be associated with the spectacular action movie.  Doubtless success is the fact that only during one year period after the product launch, resuscitation specialists and surgeons have not only learned about Colomycin, but also came to trust it, considering the product as one of the best drugs against hospital infections caused by Gram-negative bacteria. 
Definitely, successful Ukrainian experience of Colomycin endotracheal administration to patients with severe pneumonias has become a real breakthrough in the world practice of the product use.  This is the achievement of the global importance.  There will be represented report about success of this innovative experience of treatment of patients with severe conditions at the 1st Russia-Ukraine Congress on Intensive Medical Therapy to be held in September 2010.